Overcoming Dissolution Challenges with Low-Dose Pharmaceuticals and Medical Devices

Novel dosage forms require novel dissolution techniques and instruments. Drug-eluting stent testing, transdermals, implants, contact lenses, medical devices, and a variety of other products require absolute control over evaporative losses and assurance of analytical sample integrity. The dissolution testing is frequently done using ultralow volumes in the 5–10 mL range. In this webinar, we will explore tools and techniques that address the challenges of these types of analysis by examining several examples and case studies.

Key learning objectives

• Discover dissolution techniques for novel formulations
• Explore case studies for small-volume dissolution testing
• Learn about the Agilent 400-DS

Who should attend?

• Dissolution users, lab managers in R&D and QC, and drug/device manufacturers

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.